ResearcherFujian Medical UniversityNo recent work listed
Jiawei Zheng
Matched on ORCID iD 0009-0007-5237-0504; OpenAlex author ID A5102495507. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2016: 2 papers · 2017: 1 paper · 2018: 1 paper
Papers 4
- BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. First author DOI 10.5301/ijbm.5000310↗
- Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/1010428317699131↗
- Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-015-4675-5↗
- Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. First author DOI 10.1155/2016/8137378↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xuenong Ouyang · 4 shared papers, 2016–2018 · strength 0.26
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Xiong Chen · 4 shared papers, 2016–2018 · strength 0.26
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Shanshan Huang · 3 shared papers, 2016–2018 · strength 0.20
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Yu-Fang Huang · 3 shared papers, 2016–2018 · strength 0.20
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Paper Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. DOI 10.1155/2016/8137378↗
- Yin Yin · 3 shared papers, 2016–2017 · strength 0.19
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Paper Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. DOI 10.1155/2016/8137378↗
- Yan Zhang · 1 shared paper, 2017 · strength 0.06
- Song Li · 1 shared paper, 2016 · strength 0.06
- Shanshan Huang · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.